"Norethindrone" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A synthetic progestational hormone with actions similar to those of PROGESTERONE but functioning as a more potent inhibitor of ovulation. It has weak estrogenic and androgenic properties. The hormone has been used in treating amenorrhea, functional uterine bleeding, endometriosis, and for contraception.
Descriptor ID |
D009640
|
MeSH Number(s) |
D04.210.500.668.651.693.651
|
Concept/Terms |
Norethindrone- Norethindrone
- Norpregneninolone
- Norethisterone
- Ethinylnortestosterone
|
Below are MeSH descriptors whose meaning is more general than "Norethindrone".
Below are MeSH descriptors whose meaning is more specific than "Norethindrone".
This graph shows the total number of publications written about "Norethindrone" by people in this website by year, and whether "Norethindrone" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2000 | 1 | 0 | 1 |
2002 | 0 | 1 | 1 |
2007 | 0 | 1 | 1 |
2009 | 1 | 0 | 1 |
2020 | 1 | 0 | 1 |
2022 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Norethindrone" by people in Profiles.
-
Association of Progestogens and Venous Thromboembolism Among Women of Reproductive Age. Obstet Gynecol. 2022 09 01; 140(3):477-487.
-
Elagolix Treatment for Up to 12 Months in Women With Heavy Menstrual Bleeding and Uterine Leiomyomas. Obstet Gynecol. 2020 06; 135(6):1313-1326.
-
Effects of oral contraceptives or a gonadotropin-releasing hormone agonist on ovarian carcinogenesis in genetically engineered mice. Cancer Prev Res (Phila). 2009 Sep; 2(9):792-9.
-
Injectable contraception. Clin Obstet Gynecol. 2007 Dec; 50(4):898-906.
-
Got guts? Need nerve! Gastroenterology. 2007 Apr; 132(4):1615-8.
-
Enteric glia regulate intestinal barrier function and inflammation via release of S-nitrosoglutathione. Gastroenterology. 2007 Apr; 132(4):1344-58.
-
Postmenopausal uterine bleeding profiles with two forms of continuous combined hormone replacement therapy. Menopause. 2002 Jan-Feb; 9(1):16-22.
-
Effects of continuous estrogen and estrogen-progestin replacement regimens on cardiovascular risk markers in postmenopausal women. Arch Intern Med. 2000 Nov 27; 160(21):3315-25.
-
Plasma levels and pharmacokinetics of ethynyl estrogens in various populations. I. Ethynylestradiol. Contraception. 1980 Jan; 21(1):1-16.
-
Comparative studies of the ethynyl estrogens used in oral contraceptives: effects with and without progestational agents on plasma cortisol and cortisol binding in humans, baboons, and beagles. Fertil Steril. 1977 Nov; 28(11):1182-90.